Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Wednesday, June 10, 2020 9:13:57 AM
APNEA
WatchPAT
Sleep apnea – characterized by halts in breathing during the night and lower oxygen levels – affects more than one in five adults, particularly people who are overweight.
Diagnosing sleep apnea is a challenge at any time – all the more so during the Covid-19 pandemic “as so many patients must stay at home and access to in-lab testing is limited,” says Gilad Glick, CEO of Caesarea-based Itamar Medical, which developed an apnea diagnostic device for home use given that 80% of patients with apnea go undiagnosed.
WatchPAT – “PAT” stands for “peripheral arterial signal” – collects data from oximetry, actigraphy, body position, snoring, chest motion, heart rate and PAT signal. After a night of testing, the data can be downloaded and scored in less than a minute to determine if a patient has apnea.
In April, Itamar Medical entered a deal with virtual care platform BetterNight to use WatchPAT as part of BetterNight’s sleep services, which also include home-based CPAP therapy if required.
https://www.israel21c.org/israeli-solutions-to-help-you-sleep-soundly-during-difficult-times/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM